Biological exposure metrics of beryllium-exposed dental technicians

Archives of Environmental and Occupational Health

Volumn 69, Issue 2, 2014, Pages 89-99

  Stark, Moshe ^a,b   Lerman, Yehuda ^b,c   Kapel, Arik ^c   Pardo, Asher ^b   Schwarz, Yehuda ^a   Newman, Lee ^d   Maier, Lisa ^e   Fireman, Elizabeth ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Clalit Medical Services   (Israel)

^d Food Science and Human Nutrition   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Beryllium; Bio monitoring; Dental technician; Occupational exposure; Particles exposure; Sputum induction

Indexed keywords

BERYLLIUM; HEME OXYGENASE 1;

ADULT; ARTICLE; BERYLLIOSIS; BERYLLIUM LYMPHOCYTE PROLIFERATION TEST; BIOLOGICAL MONITORING; CELL PROLIFERATION ASSAY; CHRONIC DISEASE; CONTROLLED STUDY; DENTAL ASSISTANT; DUST EXPOSURE; FEMALE; GENE; GENE EXPRESSION; HEME OXYGENASE 1 GENE; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PERSONAL HYGIENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SELF REPORT; SPUTUM ANALYSIS; SPUTUM INDUCTION; CHEMISTRY; DRUG EFFECTS; ENVIRONMENTAL MONITORING; METABOLISM; MIDDLE AGED; PROTECTIVE EQUIPMENT; SMOKING; SPUTUM; TIME; TOXICITY; DRUG EFFECT;

ADULT; BERYLLIOSIS; BERYLLIUM; DENTAL TECHNICIANS; ENVIRONMENTAL MONITORING; FEMALE; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PROTECTIVE DEVICES; REAL-TIME POLYMERASE CHAIN REACTION; SMOKING; SPUTUM; TIME FACTORS;

EID: 84891696686     PISSN: 19338244     EISSN: None     Source Type: Journal    
DOI: 10.1080/19338244.2012.744736     Document Type: Article

References (38)

1. Schuler CR, Virji MA, Deubner DC, et al. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers. Scand J Work Environ Health. 2012;38(3):270-281.
2. Rosenman K, V. Hertzberg C, Rice M.J, et al. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect. 2005;113:1366-1372.
3. Stefaniak AB, Virji MA, Day GA Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid. Chemosphere. 2011;83:1181-1187.
4. Stefaniak AB, Hoover MD, Dickerson RM, et al. Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease. AIHA J. 2003;64:297-305.
5. Stefaniak AB, Hoover MD, Day GA, et al. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit. 2004;6:523-532.
6. Day GA, Hoover MD, Stefaniak AB, et al. Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model. Exp Lung Res. 2005;31:341-360.
7. Salvi S, Blomberg A, Rudell B, et al. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med. 1999;159:702-709.
8. Sawyer RT, Dobis DR, Goldstein M, et al. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med. 2005;38:928-937.
9. Dobis DR, Sawyer RT, Gillespie MM, et al. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med. 2008;177:1002-1011.
10. Morse D. The role of heme oxygenase-1 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29(3 Suppl):S82-S86.
11. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Nat Acad Sci U S A. 1991;88:688-692.
12. Stark M, Zubareb J, Jacovovitz R, et al. HO-1 and VEGF gene expressions are time dependant during exposure to welding fumes. Cytokine. 2009;46:290-295.
13. Rybicki BA, Johnson CC, Peterson EL, Kortsha GX, Gorell JM. Comparability of different methods of retrospective exposure assessment of metals in manufacturing industries. Am J Ind Med. 1997;31: 36-43.
14. Benke G, Sim M, Fritschi L, Aldred G, Forbes A, Kauppinen T. Comparison of occupational exposure using three different methods: hygiene panel, job exposure matrix (JEM), and self reports. Appl Occup Environ Hyg. 2001;16:84-91.
15. Miller MR, Hankinson J, Brusasco V, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
16. Popov TA, Pizzichini MM, Pizzichini E, et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J. 1995;8:559-565.
17. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol. 1991;88:54-60.
18. Fireman E, Topilsky I, Greif J, et al. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir Med. 1999;93:827-834.
19. Lerman Y, Segal B, Rochvarger M, Weinberg D, Kivity O, Fireman E. Induced-sputum particle size distribution and pulmonary function in foundry workers. Arch Environ Health. 2003;58:565-571.
20. Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med. 2001;43:238-249.
21. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001;43:231-237.
22. Fireman E, Kramer MR, Kaufman N, Muller-Quernheim J, Lerman Y. Beryllium disease: first case reported in Israel. Isr Med Assoc J. 2001;3:224-225.
23. Fireman EM, Mazor O, Kramer M, Priel I, Lerman Y. Noninvasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel. Occup Environ Med. 2010;67:631-635.
24. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect. 1996;104(Suppl 5):953-956.
25. Bakke PS, Hanoa R, Gulsvik A. Relation of occupational exposure to respiratory symptoms and asthma in a general population sample: self-reported versus interview-based exposure data. Am J Epidemiol. 2001;154:477-483.
26. Richeldi L. Chronic beryllium disease: amodel for pulmonary sarcoidosis? Acta Biomed. 2005;76(Suppl 2):11-14.
27. Rodrigues EG, McClean MD, Weinberg J, Pepper LD. Beryllium sensitization and lung function among former workers at the Nevada Test Site. Am J Ind Med. 2008;51:512-523.
28. McCleskey TM, Buchner V, Field RW, Scott BL. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. Rev Environ Health. 2009;24:75-115.
29. Kolokolova L, Gustafson BÅ. Scattering by inhomogeneous particles: microwave analog experiment comparison to effective medium theories. J Quant Spectrosc Radiat Transfer. 2001;70:611-625.
30. Truce R, Crynach R, Blair R. The problem of fine particles: POWER. September 30, 2008. Available at: http://www.coalpowermag.com/environmental/the- problem-of-fine-particles-156.html.
31. Carvalhoa TC Petersb JI, Williams RO. Influence of particle size on regional lung deposition: what evidence is there? Int J Pharm. 2011;406:1-10.
32. Fireman EM, Lerman Y, Ganor E, et al. Induced sputum assessment in New York City firefighters exposed toWorld Trade Center dust. Environ Health Perspect. 2004;112:1564-1569.
33. Newman LS, Mroz MM, Balkissoon Rand Maier LA. Beryllium sensitization progresses to chronic beryllium disease a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005;171:54-60.
34. Castranova V, Frazer DG, Manley LK, Dey RD. Pulmonary alterations associated with inhalation of occupational and environmental irritants. Immunopharmacology. 2004;2:163-172.
35. Nagatomo H, Morimoto Y, Oyabu T, et al. Expression of heme oxygenase-1 in the lungs of rats exposed to crocidolite asbestos. Inhal Toxicol. 2005;17:293-296.
36. Camara NO, Soares MP. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med. 2005;38:426-435.
37. Ovrevik J, Myran TT, Refesnes M, Becher RG, Hetland RB, Schwarze PE. Mineral particles of varying composition induce differential chemokine release from epithelial lung cells: importance of physicochemical characteristics. Ann Occup Hyg. 2005;93:219-231.
38. Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest. 2002;110:1473-1482.